About Healthcare News
Novo CEO pressed by Senate to cut prices of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen told lawmakers the corporate would think about new talks with insurers with regard to the record costs of Wegovy and copyright should they pledge to help keep the medicines on their own formulari